Literature DB >> 12673030

Caffeic acid phenethyl ester (CAPE) analogues: potent nitric oxide inhibitors from the Netherlands propolis.

Takema Nagaoka1, Arjun H Banskota, Yasuhiro Tezuka, Kiyoshi Midorikawa, Katsumichi Matsushige, Shigetoshi Kadota.   

Abstract

The MeOH and water extracts of the Netherlands propolis were tested for their inhibitory activity toward nitric oxide (NO) production in lipopolysaccharide (LPS)-activated murine macrophage-like J774.1 cells. Both of the extract possessed significant NO inhibitory activity with IC(50) values of 23.8 and 51.5 microg/ml, respectively. Then 13 phenolic compounds obtained from the MeOH extract showing stronger NO inhibition were examined on their NO inhibitory activities. Caffeic acid phenethyl ester (CAPE) analogues, i.e., benzyl caffeate, CAPE and cinnamyl caffeate, possessed most potent NO inhibitory activities with IC(50) values of 13.8, 7.64 and 9.53 microM, respectively, which were two- to four-fold stronger than the positive control N(G)-monomethyl-L-arginine (L-NMMA; IC(50), 32.9 microM). Further study on the synthetic analogues of CAPE revealed that both of 3-phenylpropyl caffeate (18; IC(50), 7.34 microM) and 4-phenylbutyl caffeate (19; IC(50), 6.77 microM) possessed stronger NO inhibitory activity than CAPE (10) and that elongation of alkyl side chain of alcoholic parts of caffeic acid esters enhance the NO inhibitory activity. In addition, it was found that CAPE analogues having longer carbon chain (>C(5)) in alcoholic part showed toxic effects toward J774.1 cells. This NO inhibitory effect may directly correlate with antiinflammatory properties of the Netherlands propolis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673030     DOI: 10.1248/bpb.26.487

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.

Authors:  C Pepper; J G Mahdi; A G S Buggins; S Hewamana; E Walsby; E Mahdi; A Al-Haza'a; A J Mahdi; T T Lin; L Pearce; L Morgan; I D Bowen; P Brennan; C Fegan
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

2.  Attenuation of carrageenan-induced hind paw edema and plasma TNF-α level by Philippine stingless bee (Tetragonula biroi Friese) propolis.

Authors:  Katrina Paz D Calimag; Czarina Catherine H Arbis; Therese Marie A Collantes; Jussiaea V Bariuan; Mary Jasmin C Ang; Cleofas A Cervancia; Mark Joseph M Desamero; Maria Amelita C Estacio
Journal:  Exp Anim       Date:  2020-11-25

3.  Is propolis safe as an alternative medicine?

Authors:  Maria Graça Miguel; Maria Dulce Antunes
Journal:  J Pharm Bioallied Sci       Date:  2011-10

4.  Recent trends and important developments in propolis research.

Authors:  Vassya Bankova
Journal:  Evid Based Complement Alternat Med       Date:  2005-03       Impact factor: 2.629

5.  Fibrinolytic activity and dose-dependent effect of incubating human blood clots in caffeic acid phenethyl ester: in vitro assays.

Authors:  Abuzar Elnager; Rosline Hassan; Zamzuri Idris; Zulkifli Mustafa; Nadiah Wan-Arfah; S A Sulaiman; Siew Hua Gan; Wan Zaidah Abdullah
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

6.  Synthesis, preliminary bioevaluation and computational analysis of caffeic acid analogues.

Authors:  Zhiqian Liu; Jianjun Fu; Lei Shan; Qingyan Sun; Weidong Zhang
Journal:  Int J Mol Sci       Date:  2014-05-16       Impact factor: 5.923

Review 7.  Cardiovascular Effects of Caffeic Acid and Its Derivatives: A Comprehensive Review.

Authors:  Henrique Silva; Nuno Miguel F Lopes
Journal:  Front Physiol       Date:  2020-11-27       Impact factor: 4.566

8.  Characterization and antioxidant properties of six Algerian propolis extracts: ethyl acetate extracts inhibit myeloperoxidase activity.

Authors:  Yasmina Mokhtaria Boufadi; Jalal Soubhye; Ali Riazi; Alexandre Rousseau; Michel Vanhaeverbeek; Jean Nève; Karim Zouaoui Boudjeltia; Pierre Van Antwerpen
Journal:  Int J Mol Sci       Date:  2014-02-07       Impact factor: 5.923

9.  Interleukin-10 and Interleukin-1β Cytokines Expression in Leukocytes of Patients with Chronic Peri-Mucositis.

Authors:  Darius Gleiznys; Alvydas Gleiznys; Lina Abraškevičiūtė; Astra Vitkauskienė; Viktoras Šaferis; Jurgina Sakalauskienė
Journal:  Med Sci Monit       Date:  2019-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.